BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22366797)

  • 1. Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice.
    Ghazi-Noori S; Froud KE; Mizielinska S; Powell C; Smidak M; Fernandez de Marco M; O'Malley C; Farmer M; Parkinson N; Fisher EM; Asante EA; Brandner S; Collinge J; Isaacs AM
    Brain; 2012 Mar; 135(Pt 3):819-32. PubMed ID: 22366797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia.
    Vernay A; Therreau L; Blot B; Risson V; Dirrig-Grosch S; Waegaert R; Lequeu T; Sellal F; Schaeffer L; Sadoul R; Loeffler JP; René F
    Hum Mol Genet; 2016 Aug; 25(15):3341-3360. PubMed ID: 27329763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
    Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA
    Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology.
    Clayton EL; Mizielinska S; Edgar JR; Nielsen TT; Marshall S; Norona FE; Robbins M; Damirji H; Holm IE; Johannsen P; Nielsen JE; Asante EA; Collinge J; ; Isaacs AM
    Acta Neuropathol; 2015 Oct; 130(4):511-23. PubMed ID: 26358247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tau-pathology on charged multivesicular body protein 2b (CHMP2B).
    Midani-Kurçak JS; Dinekov M; Puladi B; Arzberger T; Köhler C
    Brain Res; 2019 Mar; 1706():224-236. PubMed ID: 30414727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation.
    Clayton EL; Mancuso R; Nielsen TT; Mizielinska S; Holmes H; Powell N; Norona F; Larsen JO; Milioto C; Wilson KM; Lythgoe MF; Ourselin S; Nielsen JE; Johannsen P; Holm I; Collinge J; ; Oliver PL; Gomez-Nicola D; Isaacs AM
    Hum Mol Genet; 2017 Mar; 26(5):873-887. PubMed ID: 28093491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel synaptopathy-defective synaptic vesicle protein trafficking in the mutant CHMP2B mouse model of frontotemporal dementia.
    Clayton EL; Bonnycastle K; Isaacs AM; Cousin MA; Schorge S
    J Neurochem; 2022 Feb; 160(3):412-425. PubMed ID: 34855215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal transcriptomic analysis of altered pathways in a CHMP2B
    Waegaert R; Dirrig-Grosch S; Parisot F; Keime C; Henriques A; Loeffler JP; René F
    Neurobiol Dis; 2020 Mar; 136():104710. PubMed ID: 31837425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CHMP2B
    Krasniak CS; Ahmad ST
    Brain Res; 2016 Oct; 1649(Pt B):151-157. PubMed ID: 26972529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontotemporal dementia caused by CHMP2B mutations.
    Isaacs AM; Johannsen P; Holm I; Nielsen JE;
    Curr Alzheimer Res; 2011 May; 8(3):246-51. PubMed ID: 21222599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.
    Verbeeck C; Deng Q; Dejesus-Hernandez M; Taylor G; Ceballos-Diaz C; Kocerha J; Golde T; Das P; Rademakers R; Dickson DW; Kukar T
    Mol Neurodegener; 2012 Oct; 7():53. PubMed ID: 23046583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations.
    Urwin H; Authier A; Nielsen JE; Metcalf D; Powell C; Froud K; Malcolm DS; Holm I; Johannsen P; Brown J; Fisher EM; van der Zee J; Bruyland M; ; Van Broeckhoven C; Collinge J; Brandner S; Futter C; Isaacs AM
    Hum Mol Genet; 2010 Jun; 19(11):2228-38. PubMed ID: 20223751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endosomal sorting related protein CHMP2B is localized in Lewy bodies and glial cytoplasmic inclusions in α-synucleinopathy.
    Tanikawa S; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2012 Oct; 527(1):16-21. PubMed ID: 22947304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enhanced association between mutant CHMP2B and spastin is a novel pathological link between frontotemporal dementia and hereditary spastic paraplegias.
    Chen Y; Krishnan G; Parsi S; Pons M; Nikolaki V; Cao L; Xu Z; Gao FB
    Acta Neuropathol Commun; 2022 Nov; 10(1):169. PubMed ID: 36414997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of microglial metabolism and inflammatory profile contributes to neurotoxicity in a hiPSC-derived microglia model of frontotemporal dementia 3.
    Haukedal H; Syshøj Lorenzen S; Winther Westi E; Corsi GI; Gadekar VP; McQuade A; Davtyan H; Doncheva NT; Schmid B; Chandrasekaran A; Seemann SE; Cirera S; Blurton-Jones M; Meyer M; Gorodkin J; Aldana BI; Freude K
    Brain Behav Immun; 2023 Oct; 113():353-373. PubMed ID: 37543250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontotemporal lobar degeneration with ubiquitin-positive inclusions: a molecular genetic update.
    van der Zee J; Gijselinck I; Pirici D; Kumar-Singh S; Cruts M; Van Broeckhoven C
    Neurodegener Dis; 2007; 4(2-3):227-35. PubMed ID: 17596717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines.
    Belly A; Bodon G; Blot B; Bouron A; Sadoul R; Goldberg Y
    J Cell Sci; 2010 Sep; 123(Pt 17):2943-54. PubMed ID: 20699355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of the Neuromuscular Junction and Modifications of Muscle Metabolism in Response to Neuron-Restricted Expression of the CHMP2B
    Waegaert R; Dirrig-Grosch S; Liu H; Boutry M; Luan P; Loeffler JP; René F
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of pathology in CHMP2B-mediated frontotemporal dementia patient cells using RNA interference.
    Nielsen TT; Mizielinska S; Hasholt L; Isaacs AM; Nielsen JE;
    J Gene Med; 2012 Aug; 14(8):521-9. PubMed ID: 22786763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of mutant CHMP2B, an ESCRT-III component involved in frontotemporal dementia, causes eye deformities due to Notch misregulation in Drosophila.
    Cheruiyot A; Lee JA; Gao FB; Ahmad ST
    FASEB J; 2014 Feb; 28(2):667-75. PubMed ID: 24158394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.